No abstract available
MeSH terms
-
Age Factors
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Chemotherapy, Adjuvant / adverse effects
-
Chemotherapy, Adjuvant / methods
-
Cytarabine / administration & dosage
-
Cytarabine / adverse effects
-
Disease-Free Survival
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Hematopoietic Stem Cell Transplantation*
-
Humans
-
Idarubicin / administration & dosage
-
Karyotyping
-
Leukemia, Myeloid, Acute / genetics
-
Leukemia, Myeloid, Acute / mortality
-
Leukemia, Myeloid, Acute / therapy*
-
Male
-
Middle Aged
-
Neoadjuvant Therapy / adverse effects
-
Neoadjuvant Therapy / methods*
-
Remission Induction / methods*
-
Retrospective Studies
-
Sex Factors
-
Time Factors
-
Transplantation, Homologous
-
Vidarabine / administration & dosage
-
Vidarabine / adverse effects
-
Vidarabine / analogs & derivatives
Substances
-
Cytarabine
-
Vidarabine
-
fludarabine
-
Idarubicin